Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach

被引:26
|
作者
Costantini, Susan [1 ]
Raucci, Raffaele [2 ]
De Vero, Teresa [2 ]
Castello, Giuseppe [1 ]
Colonna, Giovanni [2 ]
机构
[1] IRCCS, Fdn Giovanni Pascale, Ist Nazl Studio & Cura Tumori, I-83013 Mercogliano, AV, Italy
[2] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, Naples, Italy
关键词
CXCR3; CXCR4; CXCR7; CXCL11; CXCL12; PROTEIN; CHEMOKINES; CANCER; RECOGNITION; BINDING; INFLAMMATION; ANTAGONISTS; DOCKING; VARIANT; GROWTH;
D O I
10.1016/j.cyto.2013.05.024
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chemokine receptor trio composed by CXCR3, CXCR4 and CXCR7 represents a hard and interesting challenge for cancer biology because these three receptors are found to be over-expressed in different cancers as well as to bind the same chemokines. In fact, CXCR4 interacts with CXCL12, CXCR7 not only with CXCL12 but also with CXCL11, that is a natural ligand for CXCR3. For these reasons, it seems necessary to define and to identify the structural determinants of CXCR3, CXCR4 and CXCR7 and their related physic-chemical properties that permit them to bind CXCL11 and CXCL12. Hence in this paper we show the modeling of CXCR7 and its complex with CXCL11 and CXCL12 compared to CXCR3/CXCL11 and CXCR4/CXCL12. Our results show that (i) CXCR3, CXCR4 and CXCR7 present similar trans-membrane helices and different conformations of N-terminal and C-terminal regions as well as of three extracellular loops, and (ii) the predominant interaction between the three receptors and the two chemokines are on hydrophobic and electrostatic basis. Moreover, our data confirm that CXCL12 binds to CXCR7 with higher affinity than to CXCR4. Methodologically, we can also conclude that our computational strategy is adequate to model correctly the interactions between these chemokines and their receptors; therefore, our models represent a good structural basis to design and develop peptides able to block contemporaneously CXCR3, CXCR4 and CXCR7 receptor trio. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:316 / 321
页数:6
相关论文
共 50 条
  • [41] CXCR4/CXCR7/CXCL12 axis promotes an invasive phenotype in medullary thyroid carcinoma
    Werner, Thomas A.
    Forster, Christina M.
    Dizdar, Levent
    Verde, Pablo E.
    Raba, Katharina
    Schott, Matthias
    Knoefel, Wolfram T.
    Krieg, Andreas
    BRITISH JOURNAL OF CANCER, 2017, 117 (12) : 1837 - 1845
  • [42] Drug design strategies focusing on the CXCR4/CXCR7/CXCL12 pathway in leukemia and lymphoma
    Barbieri, Federica
    Bajetto, Adriana
    Thellung, Stefano
    Wuerth, Roberto
    Florio, Tullio
    EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (11) : 1093 - 1109
  • [43] The role of CXCL12/CXCR4/CXCR7 axis in cognitive impairment associated with neurodegenerative diseases
    Sarallah, Rojin
    Jahani, Shima
    Khaboushan, Alireza Soltani
    Moaveni, Amir Kian
    Amiri, Maryam
    Zolbin, Masoumeh Majidi
    BRAIN BEHAVIOR & IMMUNITY-HEALTH, 2025, 43
  • [44] Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer
    Alireza Nazari
    Hossein Khorramdelazad
    Gholamhossein Hassanshahi
    International Journal of Clinical Oncology, 2017, 22 : 991 - 1000
  • [45] Expression of CXCR7, CXCR4, CXCR3 and their chemokine ligands in glioblastoma.
    Berahovich, Robert D.
    Walters, Matthew J.
    Sullivan, Timothy J.
    Kohrt, Holbrook Edwin
    Karamchandani, Jason
    Jaen, Juan C.
    Schall, Thomas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [46] CXCL11 and CXCL12 modulates matrix metalloproteinase expression by breast cancer cells predominately through CXCR7 interactions
    Mosley, LaSharon
    Sharma, Praveen
    Singh, Rajesh
    Singh, Shailesh
    Lillard, James
    CANCER RESEARCH, 2009, 69
  • [47] CXCL11 and CXCL12 mediate matrix metalloproteinase expression by breast cancer cells through CXCR7
    Mosley, Lasharon D.
    Sharma, Praveen K.
    Singh, Rajesh
    Singh, Shailesh
    Lillard, James W., Jr.
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [48] CXCR4/CXCR7/CXCL12-Axis in Follicular Thyroid Carcinoma
    Werner, Thomas Artur
    Forster, Christina Maria
    Dizdar, Levent
    Verde, Pablo Emilio
    Raba, Katharina
    Schott, Matthias
    Knoefel, Wolfram Trudo
    Krieg, Andreas
    JOURNAL OF CANCER, 2018, 9 (06): : 929 - 940
  • [49] FOXP3 shRNA3对肝癌细胞趋化因子及受体CXCL12、CXCL11、CXCR4、CXCR7作用的研究
    欧希
    张光涛
    田佩凯
    陈景森
    徐喆
    谢勇
    王爱红
    刘吉奎
    刘晓平
    岭南现代临床外科, 2018, 18 (04) : 371 - 376+382
  • [50] The Chemokine Receptors CXCR4/CXCR7 and Their Primary Heterodimeric Ligands CXCL12 and CXCL12/High Mobility Group Box 1 in Pancreatic Cancer Growth and Development Finding Flow
    Shakir, Murtaza
    Tang, Daolin
    Zeh, Herbert J.
    Tang, Siu Wah
    Anderson, Carolyn J.
    Bahary, Nathan
    Lotze, Michael T.
    PANCREAS, 2015, 44 (04) : 528 - 534